Vanta Bioscience Limited

Equities

VANTABIO6

INE695X01011

Biotechnology & Medical Research

Market Closed - Bombay S.E. 06:11:29 2024-04-26 am EDT 5-day change 1st Jan Change
63 INR +2.42% Intraday chart for Vanta Bioscience Limited -5.26% +17.65%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Vanta Bioscience Bags INR12 Million Order to Conduct Technical Studies MT
Vanta Bioscience Limited Receives an Order of INR 12 Million from A Large Indian Multinational Company CI
Vanta Bioscience Limited Appoints Sangeetha Padam as Company Secretary and Compliance Officer CI
Vanta Bioscience Bags INR5.7 Million Order for Good Laboratory Practices Studies MT
Vanta Bioscience Limited Receives Order of INR 5.7 Million from Singapore Company to Carry Out GLP Studies CI
Vanta Bioscience Limited Approves the Change in Designation of Vyasmurti Madhavrao Shingatgeri from Whole Time Director to Non-Executive Director CI
Vanta Bioscience Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Vanta Bioscience Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Vanta Bioscience Limited Announces Resignation of Vidisha Rathod as Company Secretary and Compliance Officer CI
Vanta Bioscience Limited Appoints Vidisha Rathod as Company Secretary and Compliance Officer CI
Vanta Bioscience Limited Announces Resignation of Zoheb S Sayani as Company Secretary / Compliance Officer CI
Vanta Bioscience Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Vanta Bioscience to Conduct Animal and Agrochem Studies for Coromandel International MT
Vanta Bioscience Limited Receives Order of INR 11.8 Million from Coromandel International Limited CI
Vanta Bioscience Limited Announces CFO Changes CI
Vanta Bioscience Limited Reports Earnings Results for the Half Year Ended September 30, 2021 CI
Vanta Bioscience : Receives Full Accreditation from AAALAC Council MT
Vanta Bioscience : Gains Indian Accreditation to Board's Recommendation to Continue Biological Testing MT
Vanta Bioscience Limited Reports Earnings Results for the Full Year Ended March 31, 2021 CI
Vanta Bioscience Limited Announces Resignation of Sadhanala Venkata Rao as CEO CI
Vanta Bioscience Limited Announces Resignation of Sadhanala Venkata Rao as Director CI
Vanta Bioscience Limited Enters into Commercial Agreement with One of the Leading German Testing Agency CI
Vanta Bioscience Limited Reports Earnings Results for the Half Year Ended September 30, 2020 CI
1,150,000 Equity Shares of Vanta Bioscience Limited are subject to a Lock-Up Agreement Ending on 10-OCT-2020. CI
Vanta Bioscience Limited Reports Earnings Results for the Full Year Ended March 31, 2020 CI
Chart Vanta Bioscience Limited
More charts
Vanta Bioscience Limited is an India-based preclinical contract research company. The Company is providing services of testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research and environmental studies. It offers a host of preclinical safety assessment services for clientele from pharmaceutical, medical devices, nutraceuticals, feed additive, biotech, agrochemicals, cosmetics, and chemical industries. In addition, it also provides risk assessment services for evaluating the safety of the active pharmaceutical ingredients (API), excipients, extractable and leachable, including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. It also provides services for determination of health-based exposure limits, such as permitted daily exposure (PDE) or allowable daily exposure (ADE), including occupational exposure limits (OEL) for pharmaceutical manufacturers.
More about the company
  1. Stock Market
  2. Equities
  3. VANTABIO6 Stock
  4. News Vanta Bioscience Limited
  5. Vanta Bioscience : Receives Full Accreditation from AAALAC Council